Home Page
May 30, 2024--Researched by Industrial Info Resources (Sugar Land, Texas)--Global pharmaceutical firm Eli Lilly and Company (NYSE:LLY) (Indianapolis, Indiana) last week announced that it would increase its investment in a facility in Lebanon, Indiana, by a further $5.3 billion. The facility will manufacture the active pharmaceutical ingredient (API) used in drugs for obesity and diabetes.
(All Fields Required)
Site-wide Scheduled Maintenance for September 27, 2025 from 12 P.M. to 6 P.M. CDT. Expect intermittent web site availability during this time period.
×Contact Us
For More Info!
